ARCA biopharma Files 8-K
Ticker: ORKA · Form: 8-K · Filed: Aug 16, 2024 · CIK: 907654
| Field | Detail |
|---|---|
| Company | Arca Biopharma, Inc. (ORKA) |
| Form Type | 8-K |
| Filed Date | Aug 16, 2024 |
| Risk Level | low |
| Pages | 8 |
| Reading Time | 9 min |
| Key Dollar Amounts | $1.59, $5,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, corporate-update
TL;DR
ARCA biopharma filed an 8-K on Aug 16, 2024. Standard update.
AI Summary
ARCA biopharma, Inc. filed an 8-K on August 16, 2024, reporting on other events and financial statements. The company, formerly known as NUVELO INC and HYSEQ INC, is incorporated in Delaware and headquartered in Westminster, Colorado.
Why It Matters
This filing provides an update on ARCA biopharma's corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not contain any specific material events that would inherently increase risk.
Key Numbers
- 000-22873 — SEC File Number (Identifies the company's filing with the SEC.)
- 36-3855489 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- ARCA biopharma, Inc. (company) — Registrant
- NUVELO INC (company) — Former company name
- HYSEQ INC (company) — Former company name
- August 16, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is for reporting 'Other Events' and 'Financial Statements and Exhibits' as of August 16, 2024.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on August 16, 2024.
What is ARCA biopharma, Inc.'s state of incorporation?
ARCA biopharma, Inc. is incorporated in Delaware.
What are the previous names of ARCA biopharma, Inc.?
ARCA biopharma, Inc. was formerly known as NUVELO INC and HYSEQ INC.
Where is ARCA biopharma, Inc.'s principal executive office located?
The principal executive offices of ARCA biopharma, Inc. are located at 10170 Church Ranch Way, Suite 100, Westminster, Colorado, 80021.
Filing Stats: 2,366 words · 9 min read · ~8 pages · Grade level 19.1 · Accepted 2024-08-16 16:25:22
Key Financial Figures
- $1.59 — al Dividend, which ARCA estimates to be $1.59 per share of ARCA's common stock, will
- $5,000,000 — the closing of the Merger, will exceed $5,000,000. Total actual distribution of the amoun
Filing Documents
- ea0211617-8k425_arcabio.htm (8-K) — 50KB
- ea021161701ex99-1_arcabio.htm (EX-99.1) — 22KB
- 0001213900-24-070263.txt ( ) — 255KB
- abio-20240816.xsd (EX-101.SCH) — 3KB
- abio-20240816_lab.xml (EX-101.LAB) — 33KB
- abio-20240816_pre.xml (EX-101.PRE) — 22KB
- ea0211617-8k425_arcabio_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ARCA biopharma, Inc. (Registrant) Date: August 16, 2024 By: /s/ C. Jeffrey Dekker Name: C. Jeffrey Dekker Title: Chief Financial Officer 4